Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 3;102570.
doi: 10.1016/j.autrev.2020.102570. Online ahead of print.

Seven Recommendations to Rescue the Patients and Reduce the Mortality From COVID-19 Infection: An Immunological Point of View

Affiliations
Free PMC article
Review

Seven Recommendations to Rescue the Patients and Reduce the Mortality From COVID-19 Infection: An Immunological Point of View

Andreas Kronbichler et al. Autoimmun Rev. .
Free PMC article

Abstract

Now COVID-19 is causing a severe public health emergency and the mortality is rapidly increasing all over the world. In the current pandemic era, although there have been many efforts to diagnose a number of patients with symptoms or close contacts in the world to prevent the spread in the community, there is no definite guideline for the initial therapeutic approach for them and therefore, many patients have been dying due to a hyperinflammatory immunological reaction as "cytokine storm". Severe patients are hospitalized and the treatment is done, though they have not been established yet. Currently, however, no treatment is provided for those who are isolated at home or shelter until they get severe symptoms, which will increase the harms to the patients. In this review, we discuss some important points dedicated to the management of patients with COVID-19 infections, which should help reducing morbidity and mortality. In this era, we suggested 7 recommendations to rescue the patients and to reduce the morbidity and mortality due to COVID-19 based on immunological point of view.

Keywords: COVID-19; Cytokine storm; Early treatment; Mortality.

Conflict of interest statement

Declaration of Competing Interest All authors confirm to have no actual or potential conflict of interests. The opinions described in this manuscript are those from authors and do not represent the opinions of the journal or other companies.

Figures

Fig. 1
Fig. 1
The pathogenesis of COVID-19 infection and cytokine storm. ALI: acute lung injury; ARDS: acute respiratory distress syndrome; MOF: multiorgan failure; CKD: chronic kidney disease.

Similar articles

See all similar articles

References

    1. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470–473. - PMC - PubMed
    1. Bedford J., Enria D., Giesecke J., Heymann D.L., Ihekweazu C., Kobinger G. WHO Strategic and Technical Advisory Group for infectious hazards. COVID-19: towards controlling of a pandemic. Lancet. 2020 Mar 17;395(10229):1015–1018. doi: 10.1016/S0140-6736(20)30673-5. pii: S0140–6736(20)30673–5. [Epub ahead of print] No abstract available. - DOI - PubMed
    1. Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425–434. doi: 10.1016/S1473-3099(20)30086-4. pii: S1473–3099(20)30086–4. [Epub ahead of print] - DOI - PMC - PubMed
    1. Baud D., Qi X., Nielsen-Saines K., Musso D., Pomar L., Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;(Mar 12) doi: 10.1016/S1473-3099(20)30195-X. pii: S1473–3099(20)30195-X. [Epub ahead of print] No abstract available. - DOI
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506. - PMC - PubMed

LinkOut - more resources

Feedback